Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Neuerburg, J. M.
Right arrow Articles by Daus, H. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Neuerburg, J. M.
Right arrow Articles by Daus, H. J.

Radiology, Vol 172, 739-743, Copyright © 1989 by Radiological Society of North America

ARTICLES

Urinary bladder neoplasms: evaluation with contrast-enhanced MR imaging

JM Neuerburg, K Bohndorf, M Sohn, F Teufl, RW Guenther and HJ Daus
Department of Diagnostic Radiology, University of Aachen, Medical Faculty, Federal Republic of Germany.

Forty-eight patients with urinary bladder neoplasms were examined with magnetic resonance imaging before and after intravenous administration of gadolinium diethylene-triaminepentaacetic acid (DTPA). Spin-echo sequences with short repetition and echo times were used in all patients; in 20 a gradient-echo technique was used to perform sequential imaging. In 31 patients ratios of tumor signal intensity to that of fat, muscle, and bone marrow were calculated before and after Gd-DTPA enhancement on T1-weighted spin-echo images. Increases in tumor signal intensity on T1-weighted spin-echo images were statistically significant after contrast enhancement (alpha = 1%, P less than .0001). The average rise in relative signal intensity after contrast enhancement was 120% for the tumor-fat ratio (tumor-marrow ratio, 105%; tumor-muscle ratio, 85%). Tumor signal intensity peaked within 120 seconds and remained on a plateau for up to 45 minutes. Necrotic tissue within the tumor, seen in three cases, was detectable only on contrast- enhanced images.


This article has been cited by other articles:


Home page
 Am. J. Roentgenol.Home page
H. Watanabe, M. Kanematsu, H. Kondo, S. Goshima, Y. Tsuge, M. Onozuka, and N. Moriyama
Preoperative T Staging of Urinary Bladder Cancer: Does Diffusion-Weighted MRI Have Supplementary Value?
Am. J. Roentgenol., May 1, 2009; 192(5): 1361 - 1366.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
N. Tuncbilek, M. Kaplan, S. Altaner, I. H. Atakan, N. Sut, O. Inci, and M. K. Demir
Value of Dynamic Contrast-Enhanced MRI and Correlation with Tumor Angiogenesis in Bladder Cancer
Am. J. Roentgenol., April 1, 2009; 192(4): 949 - 955.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
A. Tekes, I. Kamel, K. Imam, G. Szarf, M. Schoenberg, K. Nasir, R. Thompson, and D. Bluemke
Dynamic MRI of Bladder Cancer: Evaluation of Staging Accuracy
Am. J. Roentgenol., January 1, 2005; 184(1): 121 - 127.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
V. Kundra and P. M. Silverman
Imaging in the Diagnosis, Staging, and Follow-Up of Cancer of the Urinary Bladder
Am. J. Roentgenol., April 1, 2003; 180(4): 1045 - 1054.
[Full Text] [PDF]